Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chimera Antigen Receptor (CAR)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT05023707
What this trial is testing

Anti-FLT3 CAR T-cell Therapy in FLT3 Positive Relapsed/Refractory Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
The First Affiliated Hospital of Soochow University 5
Testing effectiveness (Phase 2)Ended earlyNCT06381830
What this trial is testing

Clinical Study of CAR-T Cell Therapy Following ASCT for R/R B-cell Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma, B-CellAutologous Stem Cell Transplantation
The First Affiliated Hospital of Soochow University 8
Very early researchLooking for participantsNCT06792799
What this trial is testing

Anti-CD19/BCMA CAR-NK Cells in Patients With B Cell Mediated Autoimmune Disease

Who this might be right for
Autoimmune DiseasesSystemic Lupus ErthematosusMulti-Drug Resistant Nephrotic Syndrome+1 more
The Children's Hospital of Zhejiang University School of Medicine 36
Testing effectiveness (Phase 2)Ended earlyNCT03356795
What this trial is testing

Intervention of CAR-T Against Cervical Cancer

Who this might be right for
Cervical Cancer
Shenzhen Geno-Immune Medical Institute 20
Early research (Phase 1)Study completedNCT03483688
What this trial is testing

A PhaseⅠb Study Evaluating Safety and Efficacy of C-CAR011 Treatment in B- NHL Subjects

Who this might be right for
B-cell Non-Hodgkin Lymphoma
Peking Union Medical College Hospital 6
Early research (Phase 1)UnknownNCT05554575
What this trial is testing

Chimeric Antigen Receptor T-Cell (CAR-T) Cells in Patients With R/R T-LBL

Who this might be right for
T Cell Lymphoblastic Lymphoma
Bioceltech Therapeutics, Ltd. 15
Not applicableEnded earlyNCT03473457
What this trial is testing

CAR-T Cells Therapy in Relapsed/Refractory Acute Myeloid Leukemia

Who this might be right for
Relapsed/Refractory Acute Myeloid Leukemia(AML)
Zhujiang Hospital 2
Early research (Phase 1)Looking for participantsNCT06569472
What this trial is testing

Clinical Trial of CD19-targeted CAR-T Therapy for Refractory Juvenile Dermatomyositis

Who this might be right for
Juvenile Dermatomyositis
Chongqing Precision Biotech Co., Ltd 10
Early research (Phase 1)Active Not RecruitingNCT01860937
What this trial is testing

T-Lymphocytes Genetically Targeted to the B-Cell Specific Antigen CD19 in Pediatric and Young Adult Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia

Who this might be right for
Relapsed B-Cell Acute Lymphoblastic Leukemia
Memorial Sloan Kettering Cancer Center 23
Not applicableUnknownNCT03380039
What this trial is testing

Clinical Study of CAR-BCMA T Cells in Patients With Refractory or Relapsed Multiple Myeloma

Who this might be right for
Refractory or Relapsed Multiple Myeloma
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 6
Very early researchActive Not RecruitingNCT06765876
What this trial is testing

CART123 T Cells in Relapsed or Refractory CD123+ Hematologic Malignancies: A Dose Escalation Phase I Trial

Who this might be right for
Leukemia, Myeloid, Acute(AML)Precursor Cell Lymphoblastic Leukemia-LymphomaMyelodysplastic Syndromes (MDS)+1 more
Institute of Hematology and Blood Transfusion, Czech Republic 18
Large-scale testing (Phase 3)UnknownNCT04287660
What this trial is testing

Study of BiRd Regimen Combined With BCMA CAR T-cell Therapy in Newly Diagnosed Multiple Myeloma (MM) Patients

Who this might be right for
Multiple Myeloma
The First Affiliated Hospital of Soochow University 20
Early research (Phase 1)Study completedNCT02203825
What this trial is testing

Safety Study of Chimeric Antigen Receptor Modified T-cells Targeting NKG2D-Ligands

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic SyndromeMultiple Myeloma
Celyad Oncology SA 12
Testing effectiveness (Phase 2)UnknownNCT03166878
What this trial is testing

A Study Evaluating UCART019 in Patients With Relapsed or Refractory CD19+ Leukemia and Lymphoma

Who this might be right for
B Cell LeukemiaB Cell Lymphoma
Chinese PLA General Hospital 80
Early research (Phase 1)Looking for participantsNCT07509034
What this trial is testing

Autologous B7-H3 Chimeric Antigen Receptor T Cells in Previously Treated Extensive-Stage Small Cell Lung Cancer With Recurrent or Refractory Disease

Who this might be right for
Extensive-Stage Small Cell Lung CancerExtrapulmonary Neuroendocrine CarcinomaRecurrent or Refractory+1 more
National Cancer Institute (NCI) 40
Very early researchUnknownNCT04617704
What this trial is testing

BCMA and CD19 Targeted Fast Dual CART for Chromosomal Abnomalities High-risk BCMA+ Multiple Myeloma

Who this might be right for
Multiple Myeloma
Shanghai Changzheng Hospital 15
Early research (Phase 1)Study completedNCT02159716
What this trial is testing

CART-meso in Mesothelin Expressing Cancers

Who this might be right for
Metastatic Pancreatic (Ductal) AdenocarcinomaEpithelial Ovarian CancerMalignant Epithelial Pleural Mesothelioma
University of Pennsylvania 19
Not applicableEnded earlyNCT04614987
What this trial is testing

Serum Neurofilament Light (NfL) as a Marker for Brain Injury in Individuals Undergoing Chimeric Antigen Receptor-modified T Therapy

Who this might be right for
Neurotoxicity
Washington University School of Medicine 17
Early research (Phase 1)UnknownNCT05028933
What this trial is testing

IMC001 for Clinical Research on Advanced Digestive System Malignancies

Who this might be right for
Advanced Hepatocellular CarcinomaAdvanced Colorectal CancerAdvanced Gastric Cancer+1 more
Zhejiang University 48
Testing effectiveness (Phase 2)UnknownNCT05871684
What this trial is testing

A Combination Study of CAR-T Therapy in r/r B-NHL

Who this might be right for
Diffuse Large B Cell Lymphoma
Ruijin Hospital 48
Next Page